SPDR SER TR - S&P BIOTECH (XBI)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / S&P BIOTECH
Shares, excl. options Q3 2024
103M
Holdings value Q3 2024
$10.2B
Value change Q3 2024
+$672M
Grand Portfolio weight change Q3 2024
+0.001%
Number of holders
756
Number of buys Q3 2024
315
Number of sells Q3 2024
-336
Average buys Q3 2024 %
+0.007%
Average sells Q3 2024 %
-0.008%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 103M $10.2B +$672M $98.80 783
2024 Q2 98.6M $9.15B -$576M $92.71 759
2024 Q1 102M $9.72B +$1.46B $94.89 792
2023 Q4 84.2M $7.53B -$348M $89.29 747
2023 Q3 90.7M $6.63B +$306M $73.02 683
2023 Q2 85.9M $7.15B -$904M $83.20 710
2023 Q1 93.9M $7.16B +$184M $76.21 709
2022 Q4 92.3M $7.66B +$1.1B $83.00 739
2022 Q3 81.1M $6.44B -$142M $79.32 700
2022 Q2 84.8M $6.3B +$500M $74.27 708
2022 Q1 78.4M $7.05B +$613M $89.88 704
2021 Q4 67.3M $7.54B +$833M $111.96 710
2021 Q3 62.9M $7.91B -$446M $125.71 646
2021 Q2 66.8M $9.04B -$2.2B $135.40 673
2021 Q1 83.8M $11.4B -$1.2B $135.65 651
2020 Q4 85.6M $12.1B +$1.38B $140.78 662
2020 Q3 80.4M $8.96B -$25.6M $111.43 567
2020 Q2 83.8M $9.38B -$1.1B $111.95 541
2020 Q1 95.2M $7.37B +$1.59B $77.44 449
2019 Q4 66.2M $6.29B +$140M $95.11 500
2019 Q3 71.3M $5.44B +$153M $76.25 424
2019 Q2 66.4M $5.82B -$556M $87.71 444
2019 Q1 69.8M $6.32B +$552M $90.54 465
2018 Q4 60.6M $4.35B +$29M $71.75 440
2018 Q3 59.5M $5.71B -$131M $95.87 453
2018 Q2 60.4M $5.75B +$169M $95.19 450
2018 Q1 58.4M $5.12B +$1.13B $87.73 431
2017 Q4 45.7M $3.88B +$136M $84.87 418
2017 Q3 43.6M $3.77B -$268M $86.57 348
2017 Q2 46.6M $3.6B +$167M $77.18 312
2017 Q1 44.6M $3.09B +$590M $69.34 291
2016 Q4 36.6M $2.17B -$634M $59.19 275
2016 Q3 47M $3.11B +$342M $66.29 226
2016 Q2 42.8M $2.32B -$120M $54.08 202
2016 Q1 44.4M $2.29B +$45.9M $51.66 192
2015 Q4 43.5M $3.05B -$591M $70.20 197
2015 Q3 52.2M $3.25B +$2.25B $62.25 195
2015 Q2 15.7M $3.95B +$866M $252.24 191
2015 Q1 12.3M $2.76B +$194M $225.50 178
2014 Q4 11.6M $2.16B +$134M $186.47 151
2014 Q3 10.8M $1.68B +$65.5M $155.97 128
2014 Q2 10.4M $1.6B -$148M $153.99 127
2014 Q1 11.4M $1.62B +$285M $142.48 130